Tapewire

Nasdaq · USD

LITS

Lite Strategy, Inc.

Export transactions ↓
Tapewire entity
7396
SEC CIK
0001262104
Parsed reports
152

Last 12 months

Inside the activity.

3 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202511
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202610
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 29, 2023 Filed Oct 12, 2023 23:40 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.01 $0.00
Disclosure

SEC source: 0000929638-23-002770 · form4.xml · derivative · entry 1

HOWSON TAMAR D · CIK 0001202286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2033-09-29

F1 · derivative.exercise_date: Such option shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning October 1, 2023 and continuing on the first day of each calendar month following such date and continuing through July 1, 2024.

Read SEC document
September 29, 2023 Filed Oct 12, 2023 23:40 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.01 $0.00
Disclosure

SEC source: 0000929638-23-002769 · form4.xml · derivative · entry 1

Reynolds Thomas C · CIK 0001393945 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2033-09-29

F1 · derivative.exercise_date: Such option shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning October 1, 2023 and continuing on the first day of each calendar month following such date and continuing through July 1, 2024.

Read SEC document
September 29, 2023 Filed Oct 12, 2023 23:39 UTC
KANGO SUJAYDirector
GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.01 $0.00
Disclosure

SEC source: 0000929638-23-002768 · form4.xml · derivative · entry 1

KANGO SUJAY · CIK 0001336503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2033-09-29

F1 · derivative.exercise_date: Such option shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning October 1, 2023 and continuing on the first day of each calendar month following such date and continuing through July 1, 2024.

Read SEC document
September 22, 2023 Filed Sep 25, 2023 23:43 UTC
Nathoo Amin10% owner
Kassam Moez10% owner
SalePut Option (obligation to buy) · Derivative 9,000 $0.15 Strike: $7.00 $1,320.30
Disclosure

SEC source: 0000921895-23-002232 · form413392004ans_09252023.xml · derivative · entry 2

Anson Funds Management LP · CIK 0001491072 · 10% owner

Anson Advisors Inc. · CIK 0001581079 · 10% owner

Nathoo Amin · CIK 0001962354 · 10% owner

Kassam Moez · CIK 0001585167 · 10% owner

Anson Management GP LLC · CIK 0001491073 · 10% owner

Winson Bruce Ross · CIK 0001491069 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 9,000

Underlying: Common Stock · 900,000 shares

Expires 2023-10-20

F1 · balance_after: The filing of this Form 4 shall not be construed as an admission that Anson Funds Management LP ("Anson"), Anson Management GP LLC, the general partner of Anson ("Anson GP"), Bruce R. Winson, the manager of Anson GP, Anson Advisors Inc. ("Anson Advisors"), Amin Nathoo, a director of Anson Advisors, or Moez Kassam, a director of Anson Advisors, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the securities of MEI Pharma, Inc. (the "Issuer") purchased by Anson Investments Master Fund LP, Anson East Master Fund LP and Anson Opportunities Master Fund LP (collectively, the "Funds"), each advised by Anson and Anson Advisors.

F2 · balance_after: Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.nature: Anson and Anson Advisors hold indirectly the securities of the Issuer through the Funds, for which Anson and Anson Advisors are the Investment Advisors. Anson GP and Bruce R. Winson report the securities held indirectly by the Funds because, as the general partner of Anson and the manager of Anson GP, respectively, at the time of purchase, they controlled the disposition and voting of the securities. Mr. Nathoo and Mr. Kassam report the securities held indirectly by the Funds because, as the directors of Anson Advisors, at the time of purchase, they controlled the disposition and voting of the securities.

Read SEC document
September 22, 2023 Filed Sep 25, 2023 23:43 UTC
Nathoo Amin10% owner
Kassam Moez10% owner
PurchaseCommon Stock 48,060 $6.85 $329,331.15
Disclosure

SEC source: 0000921895-23-002232 · form413392004ans_09252023.xml · nonDerivative · entry 1

Anson Funds Management LP · CIK 0001491072 · 10% owner

Anson Advisors Inc. · CIK 0001581079 · 10% owner

Nathoo Amin · CIK 0001962354 · 10% owner

Kassam Moez · CIK 0001585167 · 10% owner

Anson Management GP LLC · CIK 0001491073 · 10% owner

Winson Bruce Ross · CIK 0001491069 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 864,188

F1 · balance_after: The filing of this Form 4 shall not be construed as an admission that Anson Funds Management LP ("Anson"), Anson Management GP LLC, the general partner of Anson ("Anson GP"), Bruce R. Winson, the manager of Anson GP, Anson Advisors Inc. ("Anson Advisors"), Amin Nathoo, a director of Anson Advisors, or Moez Kassam, a director of Anson Advisors, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the securities of MEI Pharma, Inc. (the "Issuer") purchased by Anson Investments Master Fund LP, Anson East Master Fund LP and Anson Opportunities Master Fund LP (collectively, the "Funds"), each advised by Anson and Anson Advisors.

F2 · balance_after: Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.nature: Anson and Anson Advisors hold indirectly the securities of the Issuer through the Funds, for which Anson and Anson Advisors are the Investment Advisors. Anson GP and Bruce R. Winson report the securities held indirectly by the Funds because, as the general partner of Anson and the manager of Anson GP, respectively, at the time of purchase, they controlled the disposition and voting of the securities. Mr. Nathoo and Mr. Kassam report the securities held indirectly by the Funds because, as the directors of Anson Advisors, at the time of purchase, they controlled the disposition and voting of the securities.

Read SEC document
September 22, 2023 Filed Sep 25, 2023 23:41 UTC SalePut Option (obligation to buy) · Derivative 6,000 $0.14 Strike: $7.00 $869.40
Disclosure

SEC source: 0000921895-23-002231 · form413392004fun_09252023.xml · derivative · entry 2

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 6,000

Underlying: Common Stock · 600,000 shares

Expires 2023-10-20

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
September 22, 2023 Filed Sep 25, 2023 23:41 UTC PurchaseCommon Stock 32,040 $6.85 $219,554.10
Disclosure

SEC source: 0000921895-23-002231 · form413392004fun_09252023.xml · nonDerivative · entry 1

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 460,840

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
September 21, 2023 Filed Sep 23, 2023 01:21 UTC
Nathoo Amin10% owner
Kassam Moez10% owner
PurchaseCommon Stock 33,600 $6.46 $217,109.76
Disclosure

SEC source: 0001193805-23-001317 · e618957_4-anson.xml · nonDerivative · entry 2

Anson Funds Management LP · CIK 0001491072 · 10% owner

Anson Advisors Inc. · CIK 0001581079 · 10% owner

Nathoo Amin · CIK 0001962354 · 10% owner

Kassam Moez · CIK 0001585167 · 10% owner

Anson Management GP LLC · CIK 0001491073 · 10% owner

Winson Bruce Ross · CIK 0001491069 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 816,128

F1 · balance_after: The filing of this Form 4 shall not be construed as an admission that Anson Funds Management LP ("Anson"), Anson Management GP LLC, the general partner of Anson ("Anson GP"), Bruce R. Winson, the manager of Anson GP, Anson Advisors Inc. ("Anson Advisors"), Amin Nathoo, a director of Anson Advisors, or Moez Kassam, a director of Anson Advisors, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the shares of Common Stock, $0.00000002 par value (the "Common Stock"), of MEI Pharma, Inc. (the "Issuer") purchased by Anson Investments Master Fund LP, Anson East Master Fund LP and Anson Opportunities Master Fund LP (collectively, the "Funds"), each advised by Anson and Anson Advisors.

F2 · balance_after: Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.nature: Anson and Anson Advisors hold indirectly 816,128 shares of Common Stock of the Issuer through the Funds, for which Anson and Anson Advisors are the Investment Advisors. Anson GP and Bruce R. Winson report the Common Stock held indirectly by the Funds because, as the general partner of Anson and the manager of Anson GP, respectively, at the time of purchase, they controlled the disposition and voting of the securities. Mr. Nathoo and Mr. Kassam report the Common Stock held indirectly by the Funds because, as the directors of Anson Advisors, at the time of purchase, they controlled the disposition and voting of the securities.

Read SEC document
September 21, 2023 Filed Sep 23, 2023 01:19 UTC PurchaseCommon Stock 22,400 $6.46 $144,739.84
Disclosure

SEC source: 0001193805-23-001316 · e618956_4-meipharm.xml · nonDerivative · entry 2

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 428,800

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
September 20, 2023 Filed Sep 23, 2023 01:21 UTC
Nathoo Amin10% owner
Kassam Moez10% owner
PurchaseCommon Stock 120,000 $6.01 $721,116.00
Disclosure

SEC source: 0001193805-23-001317 · e618957_4-anson.xml · nonDerivative · entry 1

Anson Funds Management LP · CIK 0001491072 · 10% owner

Anson Advisors Inc. · CIK 0001581079 · 10% owner

Nathoo Amin · CIK 0001962354 · 10% owner

Kassam Moez · CIK 0001585167 · 10% owner

Anson Management GP LLC · CIK 0001491073 · 10% owner

Winson Bruce Ross · CIK 0001491069 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 782,528

F1 · balance_after: The filing of this Form 4 shall not be construed as an admission that Anson Funds Management LP ("Anson"), Anson Management GP LLC, the general partner of Anson ("Anson GP"), Bruce R. Winson, the manager of Anson GP, Anson Advisors Inc. ("Anson Advisors"), Amin Nathoo, a director of Anson Advisors, or Moez Kassam, a director of Anson Advisors, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the shares of Common Stock, $0.00000002 par value (the "Common Stock"), of MEI Pharma, Inc. (the "Issuer") purchased by Anson Investments Master Fund LP, Anson East Master Fund LP and Anson Opportunities Master Fund LP (collectively, the "Funds"), each advised by Anson and Anson Advisors.

F2 · balance_after: Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.nature: Anson and Anson Advisors hold indirectly 816,128 shares of Common Stock of the Issuer through the Funds, for which Anson and Anson Advisors are the Investment Advisors. Anson GP and Bruce R. Winson report the Common Stock held indirectly by the Funds because, as the general partner of Anson and the manager of Anson GP, respectively, at the time of purchase, they controlled the disposition and voting of the securities. Mr. Nathoo and Mr. Kassam report the Common Stock held indirectly by the Funds because, as the directors of Anson Advisors, at the time of purchase, they controlled the disposition and voting of the securities.

Read SEC document
September 20, 2023 Filed Sep 23, 2023 01:19 UTC PurchaseCommon Stock 80,000 $6.01 $480,744.00
Disclosure

SEC source: 0001193805-23-001316 · e618956_4-meipharm.xml · nonDerivative · entry 1

Funicular Funds, LP · CIK 0001937147 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Ma-Weaver Jacob · CIK 0001922140 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Funicular Funds, LP

Disclosed balance after: 406,400

F1 · ownership.nature: The securities were purchased and are held by Funicular Funds, LP (the "Fund"). Cable Car Capital LLC ("Cable Car"), as the General Partner of the Fund, and Jacob Ma-Weaver, as the Managing Member of Cable Car, may each be deemed the beneficial owner of the shares owned by the Fund. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 16:37 UTC
Urso David MDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 166,571 $0.00 Strike: $7.50 $0.00
Disclosure

SEC source: 0000929638-23-001688 · form4.xml · derivative · entry 1

Urso David M · CIK 0001604256 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,571

Underlying: Common Stock · 166,571 shares

Expires 2033-06-02

F1 · derivative.exercise_date: One quarter of such options shall vest on June 2, 2024, and the remaining three quarters of such options shall vest monthly over a three year period beginning on June 2, 2024.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 22:16 UTC PurchaseCommon Stock 81,500 $0.23 $18,337.50
Disclosure

SEC source: 0001209191-23-014244 · doc4.xml · nonDerivative · entry 1

Baltic Charles V. III · CIK 0001533340 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,750

Read SEC document
July 05, 2022 Filed Jul 7, 2022 20:27 UTC GrantStock Option (Right to Buy) · Derivative 87.5 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025712 · doc4.xml · derivative · entry 1

DRISCOLL FREDERICK W · CIK 0001129890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires 2032-07-05

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 16:17 UTC
GHALIE RICHARD GChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 560,000 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0001567619-22-013787 · doc1.xml · derivative · entry 2

GHALIE RICHARD G · CIK 0001156208 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 560,000

Underlying: Common Stock · 560,000 shares

Expires 2032-07-05

F2 · derivative.exercise_date: One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 16:17 UTC
GHALIE RICHARD GChief Medical Officer
Tax withholdingCommon Stock 8,196 $0.54 $4,425.84
Disclosure

SEC source: 0001567619-22-013787 · doc1.xml · nonDerivative · entry 1

GHALIE RICHARD G · CIK 0001156208 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,927

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on July 5, 2022, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 16:22 UTC
Urso David MChief Operating Officer & GC
GrantStock Option (Right to Buy) · Derivative 1,050,000 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025698 · doc4.xml · derivative · entry 1

Urso David M · CIK 0001604256 · Chief Operating Officer & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,050,000

Underlying: Common Stock · 1,050,000 shares

Expires 2032-07-05

F1 · derivative.exercise_date: One-quarter of such options shall vest on July 5, 2023, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 20:27 UTC GrantStock Option (Right to Buy) · Derivative 87,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025711 · doc4.xml · derivative · entry 1

Glover Nicholas · CIK 0001578888 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires 2032-07-05

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 22:01 UTC GrantStock Option (Right to Buy) · Derivative 87,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025740 · doc4.xml · derivative · entry 1

Baltic Charles V. III · CIK 0001533340 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires 2032-07-05

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 16:25 UTC
GOLD DANIEL P PHDDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 1,496,000 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025708 · doc4.xml · derivative · entry 1

GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,496,000

Underlying: Common Stock · 1,496,000 shares

Expires 2032-07-05

F1 · derivative.exercise_date: One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 20:26 UTC GrantStock Option (Right to Buy) · Derivative 87,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025710 · doc4.xml · derivative · entry 1

HOWSON TAMAR D · CIK 0001202286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires 2032-07-05

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 20:25 UTC
Cohen CherylDirector
GrantStock Option (Right to Buy) · Derivative 87,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025709 · doc4.xml · derivative · entry 1

Cohen Cheryl · CIK 0001529371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires 2032-07-05

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 20:23 UTC
Drazba Brian G.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 350,000 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025702 · doc4.xml · derivative · entry 1

Drazba Brian G. · CIK 0001507369 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2032-07-05

F1 · derivative.exercise_date: One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 20:19 UTC
KANGO SUJAYDirector
GrantStock Option (Right to Buy) · Derivative 87,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0001567619-22-013789 · doc1.xml · derivative · entry 1

KANGO SUJAY · CIK 0001336503 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires 2032-07-05

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 20:22 UTC GrantStock Option (Right to Buy) · Derivative 87,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025700 · doc4.xml · derivative · entry 1

Reynolds Thomas C · CIK 0001393945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires 2032-07-05

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 20:22 UTC GrantStock Option (Right to Buy) · Derivative 87,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0000899243-22-025699 · doc4.xml · derivative · entry 1

White Christine Anna · CIK 0001371859 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires 2032-07-05

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
November 22, 2021 Filed Nov 23, 2021 20:22 UTC
KANGO SUJAYDirector
GrantStock Option (Right to Buy) · Derivative 58,334 $0.00 Strike: $2.69 $0.00
Disclosure

SEC source: 0001567619-21-021035 · doc1.xml · derivative · entry 1

KANGO SUJAY · CIK 0001336503 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,334

Underlying: Common Stock · 58,334 shares

Expires 2031-11-22

F1 · derivative.exercise_date: 25,000 options will vest in equal monthly installments over thirty-six months from November 22, 2021 and 33,334 options shall vest in equal monthly installments over twelve months from November 22, 2021.

Read SEC document
July 02, 2021 Filed Jul 6, 2021 18:49 UTC
Urso David MChief Operating Officer & GC
Tax withholdingCommon Stock 24,825 $2.94 $72,985.50
Disclosure

SEC source: 0001209191-21-045640 · doc4.xml · nonDerivative · entry 1

Urso David M · CIK 0001604256 · Chief Operating Officer & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,281

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on July 2, 2021, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.

Read SEC document
July 02, 2021 Filed Jul 6, 2021 18:47 UTC
GOLD DANIEL P PHDDirector · Chief Executive Officer
Tax withholdingCommon Stock 41,320 $2.94 $121,480.80
Disclosure

SEC source: 0001209191-21-045638 · doc4.xml · nonDerivative · entry 1

GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417,312

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on July 2, 2021, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 22:58 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045655 · doc4.xml · derivative · entry 1

DRISCOLL FREDERICK W · CIK 0001129890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 18:52 UTC
GHALIE RICHARD GChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 320,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045645 · doc4.xml · derivative · entry 1

GHALIE RICHARD G · CIK 0001156208 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,000

Underlying: Common Stock · 320,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 18:49 UTC
Urso David MChief Operating Officer & GC
GrantStock Option (Right to Buy) · Derivative 600,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045640 · doc4.xml · derivative · entry 2

Urso David M · CIK 0001604256 · Chief Operating Officer & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2031-07-01

F2 · derivative.exercise_date: One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 18:47 UTC
GOLD DANIEL P PHDDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 855,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045638 · doc4.xml · derivative · entry 2

GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 855,000

Underlying: Common Stock · 855,000 shares

Expires 2031-07-01

F2 · derivative.exercise_date: One-quarter of such options shall vest on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 23:03 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045666 · doc4.xml · derivative · entry 1

White Christine Anna · CIK 0001371859 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 22:59 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045658 · doc4.xml · derivative · entry 1

Glover Nicholas · CIK 0001578888 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 23:00 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045660 · doc4.xml · derivative · entry 1

HOWSON TAMAR D · CIK 0001202286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 23:02 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045663 · doc4.xml · derivative · entry 1

Reynolds Thomas C · CIK 0001393945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 22:56 UTC
Cohen CherylDirector
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045653 · doc4.xml · derivative · entry 1

Cohen Cheryl · CIK 0001529371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 22:55 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045651 · doc4.xml · derivative · entry 1

Clemens Kevan · CIK 0001316737 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 22:54 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045648 · doc4.xml · derivative · entry 1

Baltic Charles V. III · CIK 0001533340 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 22:51 UTC
Drazba Brian G.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001209191-21-045643 · doc4.xml · derivative · entry 1

Drazba Brian G. · CIK 0001507369 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: One-quarter of such options shall vest on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.

Read SEC document
May 25, 2021 Filed May 27, 2021 13:35 UTC
GOLD DANIEL P PHDDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001209191-21-036188 · doc4.xml · derivative · entry 2

GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 675,000

Underlying: Common Stock · 5,000 shares

Expires 2029-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 306,667 of the options are fully vested and currently exercisable. The remaining 368,333 options will vest in equal monthly installments through July 1, 2023.

Read SEC document
May 25, 2021 Filed May 27, 2021 13:35 UTC
GOLD DANIEL P PHDDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $2.52 $12,600.00
Disclosure

SEC source: 0001209191-21-036188 · doc4.xml · nonDerivative · entry 1

GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 458,632

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: 80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.

Read SEC document
May 03, 2021 Filed May 5, 2021 16:02 UTC
GHALIE RICHARD GChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001567619-21-009092 · doc1.xml · derivative · entry 1

GHALIE RICHARD G · CIK 0001156208 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2031-05-03

F1 · derivative.exercise_date: 1/4th of shares vest one-year from 5/03/2021, with the remaining balance of shares vesting in 36 equal amounts over three years.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 17:08 UTC SaleCommon Stock 25,000 $4.03 $100,625.00
Disclosure

SEC source: 0001209191-21-013670 · doc4.xml · nonDerivative · entry 1

DRISCOLL FREDERICK W · CIK 0001129890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Read SEC document
July 23, 2020 Filed Jul 27, 2020 13:59 UTC
GOLD DANIEL P PHDDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $1.57 $0.00
Disclosure

SEC source: 0001209191-20-043719 · doc4.xml · derivative · entry 2

GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,500

Underlying: Common Stock · 275,500 shares

Expires 2025-07-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All of the options are fully vested and currently exercisable.

Read SEC document
July 23, 2020 Filed Jul 27, 2020 13:59 UTC
GOLD DANIEL P PHDDirector · Chief Executive Officer
Exercise / conversionCommon Stock 12,000 $1.57 $18,840.00
Disclosure

SEC source: 0001209191-20-043719 · doc4.xml · nonDerivative · entry 1

GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 453,632

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: 80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 17:15 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $3.49 $0.00
Disclosure

SEC source: 0000899243-20-018615 · doc4.xml · derivative · entry 1

DRISCOLL FREDERICK W · CIK 0001129890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-07-02

F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 13:15 UTC
Urso David MChief Operating Officer & GC
GrantStock Option (Right to Buy) · Derivative 525,000 $0.00 Strike: $3.49 $0.00
Disclosure

SEC source: 0000899243-20-018614 · doc4.xml · derivative · entry 2

Urso David M · CIK 0001604256 · Chief Operating Officer & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 525,000

Underlying: Common Stock · 525,000 shares

Expires 2030-07-02

F2 · derivative.exercise_date: One-quarter of such options shall vest on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 13:15 UTC
Urso David MChief Operating Officer & GC
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-018614 · doc4.xml · nonDerivative · entry 1

Urso David M · CIK 0001604256 · Chief Operating Officer & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,106

F1 · security: Consists of a grant of restricted stock units, which shall vest on the one-year anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.